Wire Stories
Dr. Reddy’s Laboratories announces settlement of U.S. Revlimid� (lenalidomide) Capsules patent litigation with Celgene, a Bristol Myers Squibb Company
HYDERABAD, India & PRINCETON, N.J.–(BUSINESS WIRE)–Dr. Reddy�s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to...